Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis

Young, Kira A., Hosseini, Mohsen, Mistry, Jayna J., Morganti, Claudia, Mills, Taylor S., Cai, Xiurong, James, Brandon T., Nye, Griffin J., Fournier, Natalie R., Voisin, Veronique, Chegini, Ali, Schimmer, Aaron D., Bader, Gary D., Egan, Grace, Mansour, Marc R., Challen, Grant A., Pietras, Eric M., Fisher-Wellman, Kelsey H., Ito, Keisuke, Chan, Steven M. and Trowbridge, Jennifer J. (2025) Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis. Nature Communications, 16 (1). pp. 1-15. ISSN 2041-1723

[thumbnail of s41467-025-57238-2]
Preview
PDF (s41467-025-57238-2) - Published Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview

Abstract

The competitive advantage of mutant hematopoietic stem and progenitor cells (HSPCs) underlies clonal hematopoiesis (CH). Drivers of CH include aging and inflammation; however, how CH-mutant cells gain a selective advantage in these contexts is an unresolved question. Using a murine model of CH (Dnmt3aR878H/+), we discover that mutant HSPCs sustain elevated mitochondrial respiration which is associated with their resistance to aging-related changes in the bone marrow microenvironment. Mutant HSPCs have DNA hypomethylation and increased expression of oxidative phosphorylation gene signatures, increased functional oxidative phosphorylation capacity, high mitochondrial membrane potential (Δψm), and greater dependence on mitochondrial respiration compared to wild-type HSPCs. Exploiting the elevated Δψm of mutant HSPCs, long-chain alkyl-TPP molecules (MitoQ, d-TPP) selectively accumulate in the mitochondria and cause reduced mitochondrial respiration, mitochondrial-driven apoptosis and ablate the competitive advantage of HSPCs ex vivo and in vivo in aged recipient mice. Further, MitoQ targets elevated mitochondrial respiration and the selective advantage of human DNMT3A-knockdown HSPCs, supporting species conservation. These data suggest that mitochondrial activity is a targetable mechanism by which CH-mutant HSPCs gain a selective advantage over wild-type HSPCs.

Item Type: Article
Additional Information: Acknowledgements We thank Maria Telpoukhovskaia for computational analysis and all members of the Trowbridge Lab for experimental support and manuscript editing. We thank the Scientific Servicesat The Jackson Laboratory, including Brian Hoffmann and David Bennett in the Mass Spectrometry and Protein Chemistry Service for their contribution to the development and implementation of the targeted mass spectrometry SRM assay utilized in this study, Will Schott, Danielle Littlefield and Krystal Leigh-Brown in flow cytometry, and Sandy Daigle and Bill Flynn in single cell biology. We thank A.Phillip West, Ross Levine, Coleman Lindsley, and Courtney Jones for their critical input into this project.
Uncontrolled Keywords: general chemistry,general biochemistry,genetics and molecular biology,general,general physics and astronomy,das in place,reprints ,/dk/atira/pure/subjectarea/asjc/1600/1600
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 20 Nov 2026 13:56
Last Modified: 20 Nov 2026 13:56
URI: https://ueaeprints.uea.ac.uk/id/eprint/105162
DOI: 10.1038/s41467-025-57238-2

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item